Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial

BACKGROUND: The morbidity and socioeconomic effects of onchocerciasis, a parasitic disease that is primarily endemic in sub-Saharan Africa, have motivated large morbidity and transmission control programmes. Annual community-directed ivermectin treatment has substantially reduced prevalence. Elimina...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Lancet
Autores principales: Opoku, Nicholas O, Bakajika, Didier K, Kanza, Eric M, Howard, Hayford, Mambandu, Germain L, Nyathirombo, Amos, Nigo, Maurice M, Kasonia, Kambale, Masembe, Safari L, Mumbere, Mupenzi, Kataliko, Kambale, Larbelee, Jemmah P, Kpawor, Mawolo, Bolay, Kpehe M, Bolay, Fatorma, Asare, Sampson, Attah, Simon K, Olipoh, George, Vaillant, Michel, Halleux, Christine M, Kuesel, Annette C
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6172290/
https://ncbi.nlm.nih.gov/pubmed/29361335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(17)32844-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares